Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 3 de 3
Filtre
Ajouter des filtres








Gamme d'année
1.
Korean Journal of Obstetrics and Gynecology ; : 145-148, 1999.
Article Dans Coréen | WPRIM | ID: wpr-77538

Résumé

Malignant mixed miillerian tumor (MMMT) was one of the rare uterine sarcoma. This tumor is composed of sarcoma and carcinoma. Primary MMMT in the peritoneum is among the rarest sites for MMMT. MMMT is highly malignant and the prognosis is grave due to frequent recurrence and metastasis. In the world literature, only 22 cases with primary MMMT of the peritoneum have been reported and most of these were single report. We report one case of primary MMMT in the peritoneum with a brief review.


Sujets)
Métastase tumorale , Péritoine , Pronostic , Récidive , Sarcomes
2.
Korean Journal of Gynecologic Oncology and Colposcopy ; : 259-265, 1998.
Article Dans Coréen | WPRIM | ID: wpr-12747

Résumé

We compared the therapeutic effects of concomitant chemoradiotherapy (CRT) using cisplatin to single radiotherapy (RT) in uterine cervical cancer. 34 cases of non-operable uterine cervical cancer were reviewed retrospectively from Mar, 1993 to May, 1996 in St. Mary' s Hospital. The patients were randomly selected to compare the effects of both methods. 22 patients were included in CRT group and 12 patients in RT group. The results were as follows: 1. The decrease of tumor size was not significant (2.17 cm in CRT and 1.95 cm in RT) (p=0.61), but the number of responders of CRT group was larger than that of RT group significantly (p0.05) 3. The overall survival rate showed no difference between two groups (p>0.05). The disease-free survivals for 38 months were 17.02% in CRT and 11.36% in RT, but it was not significant (p>0.05). In conclusion, concomitant chemoradiotherapy showed better rate of response, but size of tumor decrease and tumor markers showed no difference. CRT might improve the overall survival and disease-free survival, although it was not significant in this study. The clinical significance of CRT remains to be determined in large randomized clinical trial.


Sujets)
Humains , Chimioradiothérapie , Cisplatine , Survie sans rechute , Radiothérapie , Études rétrospectives , Taux de survie , Marqueurs biologiques tumoraux , Tumeurs du col de l'utérus
3.
Korean Journal of Gynecologic Oncology and Colposcopy ; : 312-315, 1998.
Article Dans Coréen | WPRIM | ID: wpr-12740

Résumé

The incidence of malignant change of ovarian mature teratoma is 1~2%. The majority is squamous cell cancer, the others was adenocarcinoma. Neuroepithelial tissue was frequently detected in mature cystic teratoma, but their malignant change was extremely rare. Only, two cases of neuroblastoma of ovarian teratoma were reported in the world. We report one case of neuroblastoma arising in ovarian mature teratoma with a brief review. Our case is the third reported one in the world.


Sujets)
Femelle , Adénocarcinome , Incidence , Tumeurs épidermoïdes , Neuroblastome , Ovaire , Tératome
SÉLECTION CITATIONS
Détails de la recherche